KRT31
gene geneOn this page
Also known as Ha-1
Summary
KRT31 (keratin 31, HGNC:6448) is a protein-coding gene on chromosome 17q21.2, encoding Keratin, type I cuticular Ha1 (Q15323).
The protein encoded by this gene is a member of the keratin gene family. As a type I hair keratin, it is an acidic protein which heterodimerizes with type II keratins to form hair and nails. The type I hair keratins are clustered in a region of chromosome 17q12-q21 and have the same direction of transcription.
Source: NCBI Gene 3881 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 60 total
- MANE Select transcript:
NM_002277
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:6448 |
| Approved symbol | KRT31 |
| Name | keratin 31 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Ha-1 |
| Ensembl gene | ENSG00000094796 |
| Ensembl biotype | protein_coding |
| OMIM | 601077 |
| Entrez | 3881 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000251645
RefSeq mRNA: 1 — MANE Select: NM_002277
NM_002277
CCDS: CCDS11391
Canonical transcript exons
ENST00000251645 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000863475 | 41397192 | 41397608 |
| ENSE00001929970 | 41393721 | 41394169 |
| ENSE00002328339 | 41396420 | 41396576 |
| ENSE00002359405 | 41394848 | 41395068 |
| ENSE00002370373 | 41395462 | 41395623 |
| ENSE00002388040 | 41395245 | 41395370 |
| ENSE00002429088 | 41396913 | 41396995 |
Expression profiles
Bgee: expression breadth ubiquitous, 101 present calls, max score 88.85.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1270 / max 84.5845, expressed in 12 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 165897 | 0.1222 | 11 |
| 165896 | 0.0048 | 4 |
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellum | UBERON:0002037 | 88.85 | gold quality |
| cerebellar cortex | UBERON:0002129 | 88.81 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 88.80 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 87.70 | gold quality |
| skin of abdomen | UBERON:0001416 | 85.82 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.77 | gold quality |
| zone of skin | UBERON:0000014 | 85.40 | gold quality |
| skin of leg | UBERON:0001511 | 85.12 | gold quality |
| cortical plate | UBERON:0005343 | 82.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 77.34 | gold quality |
| esophagus mucosa | UBERON:0002469 | 75.45 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 75.26 | gold quality |
| muscle of leg | UBERON:0001383 | 68.13 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 67.62 | gold quality |
| gastrocnemius | UBERON:0001388 | 67.31 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 64.51 | gold quality |
| prefrontal cortex | UBERON:0000451 | 63.51 | gold quality |
| frontal cortex | UBERON:0001870 | 60.99 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 59.33 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 59.02 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 58.21 | gold quality |
| cerebral cortex | UBERON:0000956 | 58.19 | gold quality |
| right frontal lobe | UBERON:0002810 | 57.11 | gold quality |
| esophagus | UBERON:0001043 | 56.12 | gold quality |
| muscle tissue | UBERON:0002385 | 55.09 | gold quality |
| vagina | UBERON:0000996 | 52.94 | gold quality |
| brain | UBERON:0000955 | 52.55 | gold quality |
| primary visual cortex | UBERON:0002436 | 52.10 | gold quality |
| right lung | UBERON:0002167 | 51.38 | gold quality |
| ganglionic eminence | UBERON:0004023 | 49.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.71 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting KRT31, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-4480 | 99.42 | 66.02 | 735 |
| HSA-MIR-3145-3P | 98.85 | 69.07 | 2031 |
| HSA-MIR-655-5P | 98.74 | 65.93 | 888 |
| HSA-MIR-330-5P | 98.73 | 67.63 | 1788 |
| HSA-MIR-4266 | 98.53 | 67.29 | 1035 |
| HSA-MIR-518C-5P | 98.53 | 69.20 | 1640 |
| HSA-MIR-326 | 98.25 | 66.44 | 1565 |
| HSA-MIR-6736-5P | 98.17 | 66.43 | 760 |
| HSA-MIR-1262 | 98.17 | 66.52 | 757 |
| HSA-MIR-4701-3P | 98.17 | 66.25 | 788 |
| HSA-MIR-4438 | 97.96 | 63.70 | 947 |
| HSA-MIR-192-3P | 97.52 | 67.66 | 1001 |
| HSA-MIR-6772-3P | 97.04 | 65.89 | 784 |
| HSA-MIR-4268 | 94.45 | 64.09 | 819 |
Literature-anchored findings (GeneRIF, showing 2)
- the co-expression of LEF1 and beta-catenin, which in the hair follicle may initiate cortex cell differentiation through the induction of hair keratin hHa1 expression is not preserved in upper transitional cells of pilomatricomas. (PMID:15140206)
- K31 as a novel marker for clear secretory cells in human eccrine sweat glands. (PMID:31975318)
Cross-species orthologs
0 orthologs
Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), KRT33B (ENSG00000131738), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT84 (ENSG00000161849), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360), KRT13 (ENSG00000171401)
Protein
Protein identifiers
Keratin, type I cuticular Ha1 — Q15323 (reviewed: Q15323)
Alternative names: Hair keratin, type I Ha1, Keratin-31
All UniProt accessions (1): Q15323
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Present in scalp but not in hairless skin. Abundantly expressed in the differentiating cortex of growing (anagen) hair. Expression is restricted to the keratinocytes of the hair cortex and is absent from inner root sheath and medulla.
Miscellaneous. There are two types of hair/microfibrillar keratin, I (acidic) and II (neutral to basic).
Similarity. Belongs to the intermediate filament family.
RefSeq proteins (1): NP_002268* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002957 | Keratin_I | Family |
| IPR018039 | IF_conserved | Conserved_site |
| IPR039008 | IF_rod_dom | Domain |
Pfam: PF00038
UniProt features (14 total): region of interest 7, sequence variant 3, chain 1, domain 1, sequence conflict 1, site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q15323-F1 | 79.81 | 0.61 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 305 (stutter)
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 88 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, JAEGER_METASTASIS_DN, MODULE_45, MODULE_16, GCM_RING1, MARTINEZ_RB1_TARGETS_DN, MODULE_157, TGACATY_UNKNOWN, GOBP_EPIDERMIS_DEVELOPMENT, MODULE_88, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA
GO Biological Process (4): morphogenesis of an epithelium (GO:0002009), epidermis development (GO:0008544), epithelial cell differentiation (GO:0030855), intermediate filament organization (GO:0045109)
GO Molecular Function (4): structural constituent of cytoskeleton (GO:0005200), structural constituent of skin epidermis (GO:0030280), structural molecule activity (GO:0005198), protein binding (GO:0005515)
GO Cellular Component (6): obsolete extracellular space (GO:0005615), cytosol (GO:0005829), cytoskeleton (GO:0005856), intermediate filament (GO:0005882), keratin filament (GO:0045095), extracellular exosome (GO:0070062)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
| Keratinization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| epithelium development | 2 |
| structural molecule activity | 2 |
| tissue morphogenesis | 1 |
| tissue development | 1 |
| cell differentiation | 1 |
| intermediate filament cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| cytoskeleton | 1 |
| cytoskeleton organization | 1 |
| molecular_function | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| intermediate filament | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
1606 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRT31 | KRTAP3-2 | Q9BYR7 | 498 |
| KRT31 | LEF1 | Q9UJU2 | 486 |
| KRT31 | KLKB1 | P03952 | 472 |
| KRT31 | KRTAP3-3 | Q9BYR6 | 416 |
| KRT31 | KRTAP3-1 | Q9BYR8 | 387 |
| KRT31 | HOXC13 | P31276 | 386 |
| KRT31 | S100A3 | P33764 | 372 |
| KRT31 | OR1J1 | Q8NGS3 | 367 |
| KRT31 | DSG4 | Q86SJ6 | 362 |
| KRT31 | LCE6A | A0A183 | 355 |
| KRT31 | ATAD1 | Q8NBU5 | 354 |
| KRT31 | KRTAP4-3 | Q9BYR4 | 351 |
| KRT31 | TCHH | Q07283 | 349 |
| KRT31 | KRTAP19-7 | Q3SYF9 | 348 |
| KRT31 | OR2D2 | Q9H210 | 348 |
IntAct
1412 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRT31 | KRT6A | psi-mi:“MI:0915”(physical association) | 0.830 |
| KRT6A | KRT31 | psi-mi:“MI:0915”(physical association) | 0.830 |
| KRT31 | KRT2 | psi-mi:“MI:0915”(physical association) | 0.810 |
| KRT31 | HGS | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT31 | TXLNA | psi-mi:“MI:0915”(physical association) | 0.780 |
| HOXA1 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT31 | INPP5K | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT31 | KLC4 | psi-mi:“MI:0915”(physical association) | 0.780 |
| HGS | KRT31 | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT31 | GPS2 | psi-mi:“MI:0915”(physical association) | 0.740 |
| P2RX7 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MAPKBP1 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | ASMTL | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | AGR2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | KRT6B | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | KRT8 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | GSTP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | KRT5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | PRF1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CD33 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CCNC | KRT31 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | BTC | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | CDKN1A | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | NPBWR2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | KRT6C | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | SMCP | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | GEM | psi-mi:“MI:0915”(physical association) | 0.720 |
| LMO4 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | KRT83 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CDK18 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (589): KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid), KRT31 (Two-hybrid)
ESM2 similar proteins: A4FUZ0, A5A6M5, A5A6P3, A6QNX5, A7YWK3, B0LKP1, B1AQ75, E1AB55, O43790, O76009, O76013, P02534, P15241, P19013, P25690, P25691, P78385, P78386, P97861, Q0P5J7, Q14525, Q14532, Q14533, Q148H4, Q148H5, Q148H7, Q148H8, Q14CN4, Q15323, Q3SY84, Q497I4, Q61765, Q61897, Q62168, Q6IG03, Q6IG04, Q6IME9, Q6IMF0, Q6NXH9, Q86Y46
Diamond homologs: A1KQY9, A1L317, A1L595, A5A6M0, A5A6M5, A5A6N2, A5A6P3, A6BLY7, A6QQQ9, A7YWM2, B0LKP1, B1AQ75, O57607, O57611, O76009, O76013, O77727, O93256, P02533, P02534, P02535, P02537, P05781, P05783, P05784, P06394, P08727, P08728, P08730, P08777, P08778, P08779, P08802, P13645, P13646, P19001, P19012, P25030, P25690, P35527
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 174 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Formation of the cornified envelope | 12 | 9.8× | 2e-06 |
| Keratinization | 12 | 6.2× | 1e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 11 | 17.8× | 2e-08 |
| intermediate filament organization | 10 | 16.6× | 2e-07 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
60 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 5 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
530 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41394840:GTACT:G | donor_loss | 1.0000 |
| 17:41394843:CTCA:C | donor_gain | 1.0000 |
| 17:41394844:TCA:T | donor_loss | 1.0000 |
| 17:41394845:CAC:C | donor_loss | 1.0000 |
| 17:41394846:A:AC | donor_gain | 1.0000 |
| 17:41394847:C:CC | donor_gain | 1.0000 |
| 17:41394847:CT:C | donor_gain | 1.0000 |
| 17:41394847:CTTG:C | donor_gain | 1.0000 |
| 17:41395064:TCTCG:T | acceptor_gain | 1.0000 |
| 17:41395065:CTCG:C | acceptor_gain | 1.0000 |
| 17:41395065:CTCGC:C | acceptor_gain | 1.0000 |
| 17:41395066:TCG:T | acceptor_gain | 1.0000 |
| 17:41395066:TCGCT:T | acceptor_gain | 1.0000 |
| 17:41395067:CG:C | acceptor_gain | 1.0000 |
| 17:41395067:CGC:C | acceptor_gain | 1.0000 |
| 17:41395069:C:CC | acceptor_gain | 1.0000 |
| 17:41395070:T:A | acceptor_loss | 1.0000 |
| 17:41395071:G:C | acceptor_gain | 1.0000 |
| 17:41395071:G:GC | acceptor_gain | 1.0000 |
| 17:41395074:G:C | acceptor_gain | 1.0000 |
| 17:41395074:G:GC | acceptor_gain | 1.0000 |
| 17:41395241:ACACC:A | donor_loss | 1.0000 |
| 17:41395242:CA:C | donor_loss | 1.0000 |
| 17:41395243:ACCAG:A | donor_loss | 1.0000 |
| 17:41395366:TCGGT:T | acceptor_gain | 1.0000 |
| 17:41395367:CGGT:C | acceptor_gain | 1.0000 |
| 17:41395367:CGGTC:C | acceptor_gain | 1.0000 |
| 17:41395368:GGT:G | acceptor_gain | 1.0000 |
| 17:41395369:GT:G | acceptor_gain | 1.0000 |
| 17:41395370:TC:T | acceptor_loss | 1.0000 |
AlphaMissense
2718 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41395264:A:G | L286P | 0.997 |
| 17:41397343:C:G | R66P | 0.997 |
| 17:41395259:C:G | A288P | 0.995 |
| 17:41397340:A:G | L67P | 0.995 |
| 17:41394971:A:G | L325P | 0.994 |
| 17:41395013:A:G | L311P | 0.994 |
| 17:41395297:A:G | L275P | 0.994 |
| 17:41396944:C:G | A134P | 0.994 |
| 17:41394887:A:G | I353T | 0.993 |
| 17:41396502:A:G | L169P | 0.993 |
| 17:41397202:A:G | L113P | 0.993 |
| 17:41397310:A:G | L77P | 0.993 |
| 17:41394899:A:G | L349P | 0.992 |
| 17:41394959:C:G | R329P | 0.992 |
| 17:41395291:C:G | R277P | 0.992 |
| 17:41396481:A:G | L176P | 0.992 |
| 17:41394887:A:C | I353S | 0.991 |
| 17:41394920:A:G | L342P | 0.991 |
| 17:41395046:A:G | L300P | 0.991 |
| 17:41395246:A:G | L292P | 0.991 |
| 17:41395276:A:G | L282P | 0.991 |
| 17:41395360:A:G | L254P | 0.991 |
| 17:41396460:A:G | L183P | 0.991 |
| 17:41394944:C:G | R334P | 0.990 |
| 17:41395471:G:C | F247L | 0.990 |
| 17:41395471:G:T | F247L | 0.990 |
| 17:41395473:A:G | F247L | 0.990 |
| 17:41395538:A:G | L225P | 0.990 |
| 17:41397340:A:T | L67Q | 0.990 |
| 17:41394875:C:G | R357P | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000113340 (17:41397315 A>T), RS1001526131 (17:41397739 C>T), RS1001777836 (17:41398587 G>A), RS1001923688 (17:41396203 G>C), RS1002597644 (17:41398624 A>T), RS1002934303 (17:41398901 ATATATATATATTTTT>A), RS1003716425 (17:41393509 G>A), RS1004248566 (17:41393938 C>G), RS1004260043 (17:41394099 A>T), RS1004481883 (17:41393295 A>G), RS1004586037 (17:41395068 G>A,C), RS1004810996 (17:41393466 G>T), RS1005831599 (17:41398379 T>C,G), RS1005883883 (17:41398583 T>C), RS1006598138 (17:41397960 G>T)
Disease associations
OMIM: gene MIM:601077 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006989_5 | Brown vs. black hair color | 1.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003924 | hair color |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, decreases expression, increases expression | 2 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| 2-bromopalmitate | decreases reaction, increases abundance, increases palmitoylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases reaction, increases abundance, increases palmitoylation | 1 |
| Carmustine | decreases expression | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Phenolsulfonphthalein | affects cotreatment, increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Cadmium Chloride | decreases reaction, increases abundance, increases palmitoylation | 1 |
| beta-Naphthoflavone | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.